Furosemide versus placebo for fluid overload in intensive care patients-The randomised GODIF trial second version: Statistical analysis plan.

Sine WichmannTheis LangeAnders PernerChristian GluudTheis S ItenovRasmus E BerthelsenLars NebrichJørgen WiisAnne C BrøchnerLouise G NielsenMeike T BehzadiKjeld DamgaardAnne S AndreasenKristian StrandMikko JärvisaloThomas StrømCamilla T EschenMarianne L VangThomas HildebrandtFinn H AndersenMartin I SigurdssonKatrin M ThomarSandra K ThygesenThomas T TroelsenPanu UusaloVille JalkanenDorte IllumChristoffer SøllingFrederik KeusCarmen A PfortmuellerRebecka R WahlinMarlies OstermannAnders ÅnemanMorten H Bestle

Published in: Acta anaesthesiologica Scandinavica (2023)

EudraCT identifier: 2019-004292-40 and ClinicalTrials.org: NCT04180397.

Keyphrases

clinical trial
end stage renal disease
study protocol
newly diagnosed
phase iii
chronic kidney disease
ejection fraction
double blind
open label
prognostic factors
randomized controlled trial
placebo controlled
phase ii
patient reported outcomes
psychometric properties
patient reported